GW Pharmaceuticals

Investors looking to invest in the marijuana industry can get advice on Reddit. So, which marijuana or weed stocks are being featured on the forums?

A recent Gallup poll data found that nearly 66% of Americans support making cannabis legal. However, this figure was the same as in 2018. This suggests a standstill in the rise in support of cannabis legalization. Moreover, nine states will be voting in 2020 on measures to allow cannabis for recreational or medical use. The […]

As market analysts increasingly predict an upcoming global recession, we take a look at the impact of a recession on cannabis stocks.

The FDA has issued warning letters to 15 companies involved in illegal sales of non-psychoactive CBD products. What’s the legal market’s potential?

GW Pharmaceuticals has received a “strong buy” rating from four analysts, while eight have rated it as a “buy” or some equivalent.

On January 12, GW Pharmaceuticals announced its preliminary unaudited product sales report for the fourth quarter and 2019.

In this series, we’ll look at biotechnology companies focused on marijuana-based products and how they performed in the third quarter.

The Investment Industry Regulatory Organization of Canada imposed a trading halt on Canopy Growth at 4:11 PM EST on February 16, 2018.